Perspectives of Using Cannabidiol in Psychiatry
Perspectives of Using Cannabidiol in Psychiatry

Author(s): Cristinel Stefanescu, Cristina-Gabriela Schiopu
Subject(s): Clinical psychology, Health and medicine and law
Published by: Scientia Moralitas Research Institute
Keywords: cannabidiol; anxiety; psychosis; psychoactive; psychiatry;
Summary/Abstract: In the last years there has been an international explosion of debates and studies about using cannabidiol in medicine in a diversity of diseases, from oncological pathologies, autoimmune disorders or neurology but the most promising field, from afar, is psychiatry. In 2019, Romania was one of the countries that started discussing the potential use of cannabidiol in pediatric and adult neurology and psychiatry, discussions that divided both scientific and non-scientific worlds. Regarding psychiatry, cannabidiol, as a non-psychoactive compound, could have a spectrum of usage that range from anxiety and depression, post-traumatic stress disorder and most of all, psychotic pathologies. This paper will analyze the possibilities of using this substance for psychiatric patients, both adults and children, by describing the pharmacological attributes, pathophysiological mechanism and clinical aspects, respectively, by assessing the findings and results of the latest studies.

• Details
• Contents